Acinic cell carcinoma of the breast: A comprehensive review.


Journal

Breast (Edinburgh, Scotland)
ISSN: 1532-3080
Titre abrégé: Breast
Pays: Netherlands
ID NLM: 9213011

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 25 06 2022
revised: 03 10 2022
accepted: 19 10 2022
pubmed: 5 11 2022
medline: 27 12 2022
entrez: 4 11 2022
Statut: ppublish

Résumé

Acinic cell carcinoma of the breast is a rare special subtype of breast cancer in the category of salivary gland-type tumors. It is morphologically similar to acinic cell carcinomas of salivary glands and pancreas and has a triple-negative phenotype (estrogen receptor-negative, progesterone receptor-negative, and Her-2/neu negative). Its molecular genomic features are more similar to triple-negative breast cancer of no special type than to its salivary gland counterpart. However, the clinical course of the mammary acinic cell carcinoma appears to be less aggressive than the usual triple-negative breast carcinomas. This review comprehensively summarizes the current literature on the clinicopathologic, immunohistochemical, and molecular features of this rare and distinct subtype of breast cancer.

Identifiants

pubmed: 36332545
pii: S0960-9776(22)00177-1
doi: 10.1016/j.breast.2022.10.012
pmc: PMC9636467
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

208-216

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Azra Ajkunic (A)

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Faruk Skenderi (F)

Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina.

Nada Shaker (N)

Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Saghir Akhtar (S)

College of Medicine, QU Health, Qatar University, Doha, Qatar.

Janez Lamovec (J)

Institute of Oncology Ljubljana, Ljubljana, Slovenia.

Zoran Gatalica (Z)

Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Semir Vranic (S)

College of Medicine, QU Health, Qatar University, Doha, Qatar. Electronic address: semir.vranic@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH